Literature DB >> 23890070

Preexisting high frequencies of memory CD8+ T cells favor rapid memory differentiation and preservation of proliferative potential upon boosting.

Kathryn A Fraser1, Jason M Schenkel, Stephen C Jameson, Vaiva Vezys, David Masopust.   

Abstract

Memory CD8+ T cell quantity and quality determine protective efficacy against reinfection. Heterologous prime boost vaccination minimizes contraction of anamnestic effectors and maximizes memory CD8+ T cell quantity but reportedly erodes proliferative potential and protective efficacy. This study exploited heterologous prime boost vaccination to discover parameters regulating effector CD8+ T cell contraction and memory differentiation. When abundant memory T cells were established, boosting induced only 5-8 cell divisions, unusually rapid memory T cell differentiation as measured by phenotype and mitochondrial bioenergetic function, long-lived survival of 50% of effector T cells, and preservation of proliferative potential. Conversely, boosting in situations of low memory CD8+ T cell frequencies induced many cell divisions, increased contraction of effector cells, and caused senescence, low mitochondrial membrane potential, and poorly protective memory. Thus, anamnestic memory T cell differentiation is flexible, and abundant quantity can be achieved while maximizing protective efficacy and preserving proliferative potential.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23890070      PMCID: PMC3979587          DOI: 10.1016/j.immuni.2013.07.003

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  57 in total

1.  Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells.

Authors:  Min Wu; Andy Neilson; Amy L Swift; Rebecca Moran; James Tamagnine; Diane Parslow; Suzanne Armistead; Kristie Lemire; Jim Orrell; Jay Teich; Steve Chomicz; David A Ferrick
Journal:  Am J Physiol Cell Physiol       Date:  2006-09-13       Impact factor: 4.249

2.  Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin.

Authors:  Andrew M Intlekofer; Naofumi Takemoto; E John Wherry; Sarah A Longworth; John T Northrup; Vikram R Palanivel; Alan C Mullen; Christopher R Gasink; Susan M Kaech; Joseph D Miller; Laurent Gapin; Kenneth Ryan; Andreas P Russ; Tullia Lindsten; Jordan S Orange; Ananda W Goldrath; Rafi Ahmed; Steven L Reiner
Journal:  Nat Immunol       Date:  2005-11-06       Impact factor: 25.606

3.  Cutting edge: latecomer CD8 T cells are imprinted with a unique differentiation program.

Authors:  Warren N D'Souza; Stephen M Hedrick
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

4.  Stimulation history dictates memory CD8 T cell phenotype: implications for prime-boost vaccination.

Authors:  David Masopust; Sang-Jun Ha; Vaiva Vezys; Rafi Ahmed
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

5.  Strength of stimulus and clonal competition impact the rate of memory CD8 T cell differentiation.

Authors:  Surojit Sarkar; Volker Teichgräber; Vandana Kalia; Antonio Polley; David Masopust; Laurie E Harrington; Rafi Ahmed; E John Wherry
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

6.  Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8(+) T cell response to infection.

Authors:  Vladimir P Badovinac; Jodie S Haring; John T Harty
Journal:  Immunity       Date:  2007-06-07       Impact factor: 31.745

7.  Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor.

Authors:  Nikhil S Joshi; Weiguo Cui; Anmol Chandele; Heung Kyu Lee; David R Urso; James Hagman; Laurent Gapin; Susan M Kaech
Journal:  Immunity       Date:  2007-08       Impact factor: 31.745

8.  Spare respiratory capacity rather than oxidative stress regulates glutamate excitotoxicity after partial respiratory inhibition of mitochondrial complex I with rotenone.

Authors:  Nagendra Yadava; David G Nicholls
Journal:  J Neurosci       Date:  2007-07-04       Impact factor: 6.167

9.  Expression of IL-7 receptor alpha is necessary but not sufficient for the formation of memory CD8 T cells during viral infection.

Authors:  Timothy W Hand; Michel Morre; Susan M Kaech
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-03       Impact factor: 11.205

10.  Secondary memory CD8+ T cells are more protective but slower to acquire a central-memory phenotype.

Authors:  Ali Jabbari; John T Harty
Journal:  J Exp Med       Date:  2006-03-27       Impact factor: 14.307

View more
  49 in total

Review 1.  Tissue-resident memory T cells: local specialists in immune defence.

Authors:  Scott N Mueller; Laura K Mackay
Journal:  Nat Rev Immunol       Date:  2015-12-21       Impact factor: 53.106

2.  Shortened Intervals during Heterologous Boosting Preserve Memory CD8 T Cell Function but Compromise Longevity.

Authors:  Emily A Thompson; Lalit K Beura; Christine E Nelson; Kristin G Anderson; Vaiva Vezys
Journal:  J Immunol       Date:  2016-02-22       Impact factor: 5.422

3.  Frequency, Private Specificity, and Cross-Reactivity of Preexisting Hepatitis C Virus (HCV)-Specific CD8+ T Cells in HCV-Seronegative Individuals: Implications for Vaccine Responses.

Authors:  Shihong Zhang; Rakesh K Bakshi; Pothakamuri Venkata Suneetha; Paraskevi Fytili; Dinler A Antunes; Gustavo F Vieira; Roland Jacobs; Christoph S Klade; Michael P Manns; Anke R M Kraft; Heiner Wedemeyer; Verena Schlaphoff; Markus Cornberg
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

4.  Adenovirus vector-induced CD8⁺ T effector memory cell differentiation and recirculation, but not proliferation, are important for protective immunity against experimental Trypanosoma cruzi Infection.

Authors:  José Ronnie Vasconcelos; Mariana R Dominguez; Ramon L Neves; Jonatan Ersching; Adriano Araújo; Luara I Santos; Fernando S Virgilio; Alexandre V Machado; Oscar Bruna-Romero; Ricardo T Gazzinelli; Mauricio M Rodrigues
Journal:  Hum Gene Ther       Date:  2014-03-31       Impact factor: 5.695

Review 5.  Regulation of T cell immunity by cellular metabolism.

Authors:  Zhilin Hu; Qiang Zou; Bing Su
Journal:  Front Med       Date:  2018-08-16       Impact factor: 4.592

6.  Kinetic and phenotypic analysis of CD8+ T cell responses after priming with alphavirus replicons and homologous or heterologous booster immunizations.

Authors:  Maria Lisa Knudsen; Karl Ljungberg; Maria Kakoulidou; Linda Kostic; David Hallengärd; Juan García-Arriaza; Andres Merits; Mariano Esteban; Peter Liljeström
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

7.  Augmented replicative capacity of the boosting antigen improves the protective efficacy of heterologous prime-boost vaccine regimens.

Authors:  Pablo Penaloza-MacMaster; Jeffrey E Teigler; Rebecca C Obeng; Zi H Kang; Nicholas M Provine; Lily Parenteau; Stephen Blackmore; Joshua Ra; Erica N Borducchi; Dan H Barouch
Journal:  J Virol       Date:  2014-03-19       Impact factor: 5.103

Review 8.  Influence of time and number of antigen encounters on memory CD8 T cell development.

Authors:  Matthew D Martin; Vladimir P Badovinac
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

9.  Gammaherpesvirus latency differentially impacts the generation of primary versus secondary memory CD8+ T cells during subsequent infection.

Authors:  Erik S Barton; Sujana Rajkarnikar; P Kent Langston; Madeline J Price; Jason M Grayson
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

10.  Vaccine induction of antibodies and tissue-resident CD8+ T cells enhances protection against mucosal SHIV-infection in young macaques.

Authors:  Caroline Petitdemange; Sudhir Pai Kasturi; Pamela A Kozlowski; Rafiq Nabi; Clare F Quarnstrom; Pradeep Babu Jagadeesh Reddy; Cynthia A Derdeyn; Lori M Spicer; Parin Patel; Traci Legere; Yevgeniy O Kovalenkov; Celia C Labranche; François Villinger; Mark Tomai; John Vasilakos; Barton Haynes; C Yong Kang; James S Gibbs; Jonathan W Yewdell; Dan Barouch; Jens Wrammert; David Montefiori; Eric Hunter; Rama R Amara; David Masopust; Bali Pulendran
Journal:  JCI Insight       Date:  2019-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.